Protective effect of growth differentiation factor 15 in sepsis by regulating macrophage polarization and its

Xinliang Zhang1, Shimin Dong1

  • 1Department of Emergency Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Bioengineered
|April 14, 2022
PubMed

Insights

Growth Differentiation Factor 15 (GDF15) protects against sepsis by shifting macrophage polarization towards an anti-inflammatory state via the PI3K/Akt pathway. Elevated serum GDF15 levels in sepsis patients indicate severity and predict mortality.

Area of Science:

  • Biomedical research
  • Immunology
  • Sepsis pathophysiology

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Macrophage polarization plays a critical role in sepsis progression and outcomes.
  • Growth Differentiation Factor 15 (GDF15) is a stress-induced cytokine with potential immunomodulatory functions.

Purpose of the Study:

  • To investigate the protective effects of GDF15 in sepsis.
  • To elucidate the mechanism of GDF15 in regulating macrophage polarization.
  • To assess GDF15 as a prognostic marker for sepsis severity and mortality.

Main Methods:

  • Primary mouse macrophages were stimulated with lipopolysaccharide (LPS) and treated with GDF15 and PI3K inhibitor LY294002.
  • Macrophage polarization (M1/M2), mRNA expression of key signaling molecules (PI3K, Akt), survival rates, cardiac function, and histopathology were analyzed.
  • Serum GDF15 levels were measured in sepsis patients and correlated with clinical severity and mortality.

Main Results:

  • GDF15 treatment reversed LPS-induced M1 macrophage polarization to M2, reducing cardiac inflammation and improving survival in mice.
  • GDF15 activated the PI3K/Akt signaling pathway, mediating its anti-inflammatory and protective effects.
  • Increased serum GDF15 levels in sepsis patients correlated significantly with disease severity and 28-day mortality.

Conclusions:

  • GDF15 exerts protective effects in sepsis by promoting M2 macrophage polarization through the PI3K/Akt pathway.
  • GDF15 demonstrates therapeutic potential for sepsis and serves as a valuable prognostic biomarker for disease severity and patient outcomes.